284 related articles for article (PubMed ID: 38338919)
1. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review.
Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsies in pancreatic cancer.
Kamyabi N; Bernard V; Maitra A
Expert Rev Anticancer Ther; 2019 Oct; 19(10):869-878. PubMed ID: 31533487
[No Abstract] [Full Text] [Related]
5. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer.
Watanabe F; Suzuki K; Noda H; Rikiyama T
World J Gastroenterol; 2022 Dec; 28(46):6478-6496. PubMed ID: 36569270
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer.
Rofi E; Vivaldi C; Del Re M; Arrigoni E; Crucitta S; Funel N; Fogli S; Vasile E; Musettini G; Fornaro L; Falcone A; Danesi R
Pharmacogenomics; 2019 Jan; 20(1):49-68. PubMed ID: 30520336
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
Wang K; Wang X; Pan Q; Zhao B
Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
[TBL] [Abstract][Full Text] [Related]
8. Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.
Raufi AG; May MS; Hadfield MJ; Seyhan AA; El-Deiry WS
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835649
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis.
Karimi F; Azadbakht O; Veisi A; Sabaghan M; Owjfard M; Kharazinejad E; Dinarvand N
Med Oncol; 2023 Aug; 40(9):265. PubMed ID: 37561363
[TBL] [Abstract][Full Text] [Related]
10. Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication.
Hou J; Li X; Xie KP
Mol Cancer; 2021 Feb; 20(1):34. PubMed ID: 33593396
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management.
Cucchiara F; Scarpitta R; Crucitta S; Scatena C; Arici R; Naccarato AG; Fogli S; Danesi R; Del Re M
Pharmacogenomics; 2022 Jan; 23(2):119-134. PubMed ID: 35006002
[TBL] [Abstract][Full Text] [Related]
12. Liquid Biopsy in Solid Malignancy.
Scarlotta M; Simsek C; Kim AK
Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.
Gao Y; Zhu Y; Yuan Z
Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495
[TBL] [Abstract][Full Text] [Related]
14. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers.
Kaczor-Urbanowicz KE; Cheng J; King JC; Sedarat A; Pandol SJ; Farrell JJ; Wong DTW; Kim Y
Pancreas; 2020 Oct; 49(9):1141-1152. PubMed ID: 33003085
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
[No Abstract] [Full Text] [Related]
17. Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma - Mini-Review.
Liberko M; Kolostova K; Szabo A; Gurlich R; Oliverius M; Soumarova R
In Vivo; 2021; 35(1):31-39. PubMed ID: 33402447
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of
Cayrefourcq L; Alix-Panabières C
Expert Rev Mol Diagn; 2020 Sep; 20(9):913-919. PubMed ID: 32856493
[TBL] [Abstract][Full Text] [Related]
19. Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis.
Yin L; Pu N; Thompson E; Miao Y; Wolfgang C; Yu J
Clin Cancer Res; 2021 Feb; 27(3):740-748. PubMed ID: 33082211
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsies for management of pancreatic cancer.
Samandari M; Julia MG; Rice A; Chronopoulos A; Del Rio Hernandez AE
Transl Res; 2018 Nov; 201():98-127. PubMed ID: 30118658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
